Skip to Content

ALV 317 (Nevirapine Extended Release 400 mg)

Pill with imprint ALV 317 is White, Capsule-shape and has been identified as Nevirapine Extended Release 400 mg. It is supplied by Alvogen Inc..

Nevirapine is used in the treatment of reduction of perinatal transmission of hiv; hiv infection and belongs to the drug class NNRTIs. There is no proven risk in humans during pregnancy. Nevirapine 400 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ALV 317

Nevirapine extended release 400 mg ALV 317

Nevirapine Extended Release

Imprint
ALV 317
Strength
400 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nnrtis
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Alvogen Inc.
National Drug Code (NDC)
47781-0317

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.